Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 713 results for "lymphocyte count"

FACSCount CD4 and Pima CD4 T-Cell Count Systems

Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997;126:946954. O'Gorman MR, Zijenah LS. CD4 T cell measurements in the management of antiretroviral ... Medscape, 2 weeks ago

Lymphocyte count predicts papillary RCC patient survival

medwireNews: Lymphopenia is a significant predictor of outcome in patients undergoing surgery for papillary renal cell carcinoma (PRCC), US researchers report. The team says that the preoperative absolute lymphocyte count (ALC), a marker of ...
 MedWire News1 month ago Prognostic value of hematologic parameters in patients with metastatic renal cell carcinoma using tyrosine kinase inhibitors - Abstract  UroToday2 weeks ago Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder - Abstract  UroToday1 month ago
Emirates Week

Study Modification: Lymphocyte counts

AUTHOR: Cusanovich DA STUDY DATE: January 27, 2012 TITLE: The combination of a genome-wide association study of lymphocyte count and analysis of gene expression data reveals novel asthma
 National Human Genome Research Institute4 days ago Clinical Study in the Journal of Clinical Oncology Reports Patients with Diffuse Large B-Cell Lymphoma Receiving Oral REVLIMID with Standard R-CHOP Achieved 98% Overall Response Rate and 80% Complete Response Rate  Emirates Week4 weeks ago CELGENE : Clinical Study in the Journal of Clinical Oncology Reports Patients with Diffuse Large B-Cell Lymphoma Receiving Oral REVLIMID with Standard R-CHOP Achieved 98% Overall Response Rate and 80% Complete Response Rate  4 Traders1 month ago Phase III FIRST(TM) (MM-020/IFM 07-01) Trial of REVLIMID® (lenalidomide) Plus Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Who Are Not Candidates for Stem Cell Transplant Published in New England Journal of Medicine  CNBC2 weeks ago
[x]  

New cholesterol guidelines can significantly help reduce cardiovascular events

Lymphocyte count predicts papillary RCC patient survival Physical activity fails to show link with chronic musculoskeletal pain A study from UT-Southwestern researchers found that recently introduced cholesterol guidelines would significantly ...
 News-Medical.Net1 month ago Study on patients with type 2 diabetes examines fracture risk with antihypertensive treatment  News-Medical.Net1 month ago
Examiner.com

Atypical Chronic Lymphocytic Leukemia Identified by Digital Microscopy

Image: Photomicrograph of a blood film from a patient with atypical chronic lymphocytic leukemia. Lymphocytes were primarily small with round nuclei, condensed chromatin and scant cytoplasm. Approximately 20% of the lymphocytes had the morphologic ...
 Lab Medica1 week ago Imbruvica gains breakthrough status for treating chronic lymphocytic leukemia  Examiner.com1 month ago IMBRUVICA® (ibrutinib) Receives Regular Approval by U.S. FDA in Chronic Lymphocytic Leukemia (CLL) and CLL patients with del 17p  Financial Content1 month ago 7/28/14 - IMBRUVICA® (ibrutinib) Receives Regular Approval by U.S. FDA in Chronic Lymphocytic Leukemia (CLL) and CLL patients with del 17p  Pharmacy Choice1 month ago
[x]  

Roche receives EC approval for chronic lymphocytic leukemia drug

Roche has received approval from the European Commission, or EC, for Gazyvaro in combination with chlorambucil chemotherapy for the treatment of people with previously untreated chronic lymphocytic leukemia who have comorbidities making them ...
 Individual.com1 month ago EU approves Roche's Gazyvaro to treat patients with most common type of leukaemia  PharmaBiz1 month ago Roche's Gazyvaro approved in Europe for patients with the most common type of leukemia  Noodls1 month ago Roche???s Gazyvaro Approved In Europe For Patients With The Most Common Type Of Leukemia  BioSpace1 month ago
[x]  

Amgen: Grappling With The Reality Of Patent Expiries

Summary Amgen has been recently awarded the breakthrough status for its new drug to treat adults with acute lymphoblastic leukemia. The prevalence rate is quite high, with limited treatment options available. If authorized, Amgen can exploit the ...
 Seeking Alpha2 months ago
Reuters

Record-Breaking Year for The Leukemia & Lymphoma Society's Man & Woman of the Year campaign

-COMMUNITY LEADERS RAISED $30.5 MILLION TO HELP FIND CANCER CURES- PR Newswire WHITE PLAINS, N.Y., July 17, 2014 WHITE PLAINS, N.Y., July 17, 2014 /PRNewswire/ -- A Chicago man and Los Angeles woman raised $386,284 and $343,962, ...
 Reuters2 months ago
[x]  

U.S. FDA Grants Regular (Full) Approval for IMBRUVICA® for Two Indications

Previously Treated Chronic Lymphocytic Leukemia (CLL) Based on Statistically Significant Progression-Free and Overall Survival Benefits SUNNYVALE, Calif., July 28, 2014 /PRNewswire/ — Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that the ...
 Red Orbit1 month ago PHARMACYCLICS : U.S. FDA Grants Regular (Full) Approval for IMBRUVICA® for Two Indications  4 Traders1 month ago Pharmacyclics: U.S. FDA Grants Regular Approval for Imbruvica [Manufacturing Close - Up]  Pharmacy Choice1 month ago
[x]  

U.S. Food and Drug Administration Approves Gilead's Zydelig® (idelalisib) for Relapsed Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Zydelig® (idelalisib) 150 mg tablets for the treatment of three B-cell blood cancers. Zydelig is indicated in combination with ...
 Industrial Info Financials1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less